Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival.

The effect of ursodeoxycholic acid treatment on survival in primary biliary cirrhosis was studied in 40 patients with symptomatic disease. Two patients developed early exacerbation of symptoms and stopped therapy in days; they are both alive 4 and 4 1/2 years later. The other 38 patients have continued on treatment for up to 10 years. Results were compared with 12 other similar cases previously seen but not given specific therapy. Kaplan-Meier analysis showed that ursodeoxycholic acid treatment was associated with better survival (p < 0.05) after the first two years of therapy. Predictors of favourable outcome included histological stage I disease. In 26 patients with primary biliary cirrhosis stage II, III or IV, therapy showed a trend to improved survival, but this was still significantly worse than the general population. Prognosis was not different between these different advanced stages. Symptoms improved in 28 out of 40 patients on ursodeoxycholic acid, but 50% had a recurrence by two years.

[1]  E. Dickson,et al.  Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. , 1997, Gastroenterology.

[2]  K. Einarsson,et al.  Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study. , 1997, Scandinavian journal of gastroenterology.

[3]  David E. J. Jones,et al.  Natural history of early primary biliary cirrhosis , 1996, The Lancet.

[4]  T. Therneau,et al.  Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. , 1996, Gastroenterology.

[5]  K. Setchell,et al.  Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. , 1996, Gut.

[6]  E. Dickson,et al.  Time course of histological progression in primary biliary cirrhosis , 1996, Hepatology.

[7]  T. Northfield,et al.  The ursodeoxycholic acid story in primary biliary cirrhosis. , 1995, Gut.

[8]  J. Boyer,et al.  Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. , 1995, Journal of Hepatology.

[9]  B. Balkau,et al.  Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. , 1994, The New England journal of medicine.

[10]  U. Steinbrecher,et al.  The canadian multicenter double‐blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis , 1994, Hepatology.

[11]  D. Heuman,et al.  Hepatoprotective properties of ursodeoxycholic acid. , 1993, Gastroenterology.

[12]  Y. Chrétien,et al.  Serum bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid therapy , 1993, Hepatology.

[13]  P. Battezzati,et al.  Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration , 1991, Hepatology.

[14]  P. Kelly,et al.  Symptom development and prognosis in primary biliary cirrhosis: a study in two centers. , 1990, Gastroenterology.

[15]  P. Grambsch,et al.  Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. , 1990, Gastroenterology.

[16]  S. Katz,et al.  Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis , 1989, Hepatology.

[17]  Y. Chrétien,et al.  IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS? , 1987, The Lancet.

[18]  P. Ross,et al.  Ursodeoxycholic acid therapy and biliary lipids--a dose-response study. , 1980, Gut.